Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Baudax Bio (BXRX)
OTHER OTC:BXRX
Holding BXRX?
Track your performance easily
BXRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $3.47
Previous Close$0.02
Volume310.87K
Average Volume (3M)474.63K
Market Cap
$780.32K
Enterprise Value$8.14M
Total Cash (Recent Filing)$1.42M
Total Debt (Recent Filing)$8.77M
Price to Earnings (P/E)―
Beta1.66
Next Earnings
May 02, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.16
Shares Outstanding43,593,082
10 Day Avg. Volume377,044
30 Day Avg. Volume474,630
Standard Deviation0.33
R-Squared0.07
Alpha-0.18
Financial Highlights & Ratios
Price to Book (P/B)-0.04
Price to Sales (P/S)0.70
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue13.77
Enterprise Value/Gross Profit-0.82
Enterprise Value/Ebitda-0.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Baudax Bio News
Ownership Overview
1.42%
Insiders
0.11% Mutual Funds
<0.01% Other Institutional Investors
98.46% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BXRX FAQ
What was Baudax Bio’s price range in the past 12 months?
Baudax Bio lowest stock price was $0.01 and its highest was $3.47 in the past 12 months.
What is Baudax Bio’s market cap?
Currently, no data Available
When is Baudax Bio’s upcoming earnings report date?
Baudax Bio’s upcoming earnings report date is May 02, 2024 which is 122 days ago.
How were Baudax Bio’s earnings last quarter?
Currently, no data Available
Is Baudax Bio overvalued?
According to Wall Street analysts Baudax Bio’s price is currently Overvalued.
Does Baudax Bio pay dividends?
Baudax Bio does not currently pay dividends.
What is Baudax Bio’s EPS estimate?
Baudax Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Baudax Bio have?
Baudax Bio has 43,593,082 shares outstanding.
What happened to Baudax Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Baudax Bio?
Currently, no hedge funds are holding shares in BXRX
---
Baudax Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.16%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.55%
Trailing 12-Months
Company Description
Baudax Bio
Baudax Bio, Inc. is a pharmaceutical company focusing on developing and commercializing products for acute care settings. The company was founded in 2015 and is headquartered in Malvern, PA.
---
BXRX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---